Beijing Jingwei Yankang Pharmaceutical Research Institute

Beijing Jingwei Yankang Pharmaceutical Research Institute is the dedicated research and development subsidiary of the Beijing Jingwei Pharmaceutical Group. Established in 2002 and headquartered in the Beijing Economic-Technological Development Area, the institute specializes in the development of high-end generic drugs and innovative small molecule therapeutics. Its core competencies include chemical synthesis, formulation research, and pharmaceutical analysis, with a strong focus on therapeutic areas such as the central nervous system, cardiovascular diseases, and anti-infectives. The institute plays a critical role in the group's vertical integration, bridging the gap between laboratory discovery and large-scale manufacturing. In addition to internal projects, it provides technology transfer and technical consulting services to the broader pharmaceutical industry in China.